InvestorsHub Logo
Followers 13
Posts 1997
Boards Moderated 0
Alias Born 04/16/2010

Re: None

Monday, 05/22/2017 7:26:45 PM

Monday, May 22, 2017 7:26:45 PM

Post# of 73162
Let talk about revenue improvement. Last Q 12/31/16 $42,408, and 3/31/17 of $18,500 and $68,348. Up $44,440.
*Does anyone know what is accounts receivable of $371,565? please help me to understand clear, please.


The Company had revenues of $18,500 and $68,348 for the three months ended March 31, 2017 and 2016, respectively. The Company generated revenues primarily from sales of its Viabecline antibiotic which presently is sold primarily through local physicians and a license fee.

The Company had accounts receivable from related party in amount of $371,565 as of March 31, 2017 due to the related party sales in 2016 and 2015.